Cassava Sciences Inc (SAVA)
20.74
+0.19
(+0.92%)
USD |
NASDAQ |
Apr 24, 16:00
20.45
-0.29
(-1.40%)
After-Hours: 05:36
Cassava Sciences Price to Book Value: 6.522 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 6.522 |
| April 23, 2024 | 6.462 |
| April 22, 2024 | 6.446 |
| April 19, 2024 | 6.176 |
| April 18, 2024 | 6.663 |
| April 17, 2024 | 6.688 |
| April 16, 2024 | 6.613 |
| April 15, 2024 | 6.292 |
| April 12, 2024 | 7.154 |
| April 11, 2024 | 8.21 |
| April 10, 2024 | 7.707 |
| April 09, 2024 | 7.987 |
| April 08, 2024 | 7.411 |
| April 05, 2024 | 6.701 |
| April 04, 2024 | 6.440 |
| April 03, 2024 | 6.471 |
| April 02, 2024 | 6.198 |
| April 01, 2024 | 6.38 |
| March 28, 2024 | 6.38 |
| March 27, 2024 | 6.421 |
| March 26, 2024 | 6.198 |
| March 25, 2024 | 6.194 |
| March 22, 2024 | 6.229 |
| March 21, 2024 | 6.660 |
| March 20, 2024 | 6.908 |
| Date | Value |
|---|---|
| March 19, 2024 | 6.914 |
| March 18, 2024 | 6.691 |
| March 15, 2024 | 6.694 |
| March 14, 2024 | 6.506 |
| March 13, 2024 | 6.493 |
| March 12, 2024 | 6.544 |
| March 11, 2024 | 5.798 |
| March 08, 2024 | 5.905 |
| March 07, 2024 | 6.053 |
| March 06, 2024 | 6.238 |
| March 05, 2024 | 6.732 |
| March 04, 2024 | 7.078 |
| March 01, 2024 | 7.232 |
| February 29, 2024 | 7.226 |
| February 28, 2024 | 7.210 |
| February 27, 2024 | 7.232 |
| February 26, 2024 | 6.892 |
| February 23, 2024 | 6.738 |
| February 22, 2024 | 6.916 |
| February 21, 2024 | 6.806 |
| February 20, 2024 | 6.904 |
| February 16, 2024 | 7.297 |
| February 15, 2024 | 7.549 |
| February 14, 2024 | 7.405 |
| February 13, 2024 | 7.316 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9467
Minimum
May 20 2019
33.61
Maximum
Feb 03 2021
6.318
Average
5.647
Median
Apr 16 2020
Price to Book Value Benchmarks
| Amylyx Pharmaceuticals Inc | 0.294 |
| MannKind Corp | -- |
| Clearside Biomedical Inc | -- |
| Lantern Pharma Inc | 1.413 |
| NovaBay Pharmaceuticals Inc | 1.706 |
Price to Book Value Related Metrics
| PS Ratio | 21.15 |
| Price | 20.74 |
| Earnings Yield | -11.19% |
| Market Cap | 896.49M |
| Operating PE Ratio | 27.73 |
| Normalized PE Ratio | 4.357 |